Albert Lowe
Stock Analyst at Craig-Hallum
(1.53)
# 2,553
Out of 4,667 analysts
5
Total ratings
66.67%
Success rate
10.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Albert Lowe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics | Initiates: Buy | $11 | $3.06 | +259.48% | 1 | Oct 9, 2024 | |
| CRDF Cardiff Oncology | Initiates: Buy | $8 | $2.53 | +216.21% | 1 | Sep 6, 2024 | |
| LCTX Lineage Cell Therapeutics | Initiates: Buy | $4 | $0.64 | +523.64% | 1 | Aug 20, 2024 | |
| SKYE Skye Bioscience | Initiates: Buy | $18 | $4.28 | +320.56% | 1 | Jul 9, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $6 | $1.57 | +282.17% | 1 | May 13, 2024 |
SAB Biotherapeutics
Oct 9, 2024
Initiates: Buy
Price Target: $11
Current: $3.06
Upside: +259.48%
Cardiff Oncology
Sep 6, 2024
Initiates: Buy
Price Target: $8
Current: $2.53
Upside: +216.21%
Lineage Cell Therapeutics
Aug 20, 2024
Initiates: Buy
Price Target: $4
Current: $0.64
Upside: +523.64%
Skye Bioscience
Jul 9, 2024
Initiates: Buy
Price Target: $18
Current: $4.28
Upside: +320.56%
PMV Pharmaceuticals
May 13, 2024
Initiates: Buy
Price Target: $6
Current: $1.57
Upside: +282.17%